Intibiotics (Lactobacillus Plantarum P 17630)

Lactobacillus plantarum P 17630, the active ingredient in Intibiotics, is a probiotic presented as a vaginal preparation for intravaginal use. Marketed in the European Union, it helps restore normal vaginal microbiota and inhibits growth of pathogenic organisms, supporting vaginal health in women.

GNH USA supplies Intibiotics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for global healthcare providers. The company adheres to stringent quality standards and offers comprehensive logistics support across all continents.

Intibiotics, a vaginal probiotic, acts on the vaginal microbiome to promote a healthy balance of microorganisms.

- Bacterial vaginosis: helps restore normal flora and reduces recurrence. - Recurrent vaginal yeast infections: supports microbiota balance to lower incidence. - Post‑antibiotic therapy: replenishes lactobacilli after disruption. - Post‑gynecological surgery: promotes a healthy vaginal environment. - Menopausal vaginal atrophy: assists in maintaining acidity and microbial equilibrium.

Intibiotics may cause local or systemic reactions, although most users experience none.

Common Side Effects: - Mild vaginal irritation: transient burning or itching. - Increased discharge: slight change in vaginal secretions. - Odor change: temporary alteration in vaginal odor.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Severe infection: signs of systemic infection such as fever. - Persistent irritation: prolonged discomfort requiring medical evaluation.

Before using Intibiotics, consider the following precautions to ensure safe and effective use.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Immunocompromised patients: use with caution and monitor closely. - Known allergy: avoid if hypersensitivity to Lactobacillus species is documented. - Concurrent antibiotic therapy: may reduce probiotic efficacy; consider timing. - Store at ambient temperature: keep in the original packaging, protect from moisture.

Intibiotics has a low potential for drug interactions, but certain agents may affect its activity.

Major Interactions (Avoid): - None identified: no major interactions reported.

Moderate Interactions (Monitor Closely): - Antibiotics: may diminish probiotic colonization if taken simultaneously. - Antifungal agents: could reduce efficacy against yeast overgrowth. - Immunosuppressants: monitor for opportunistic infections. - Hormonal contraceptives: no known effect but monitor vaginal symptoms. - Vaginal douches or antiseptics: may disrupt probiotic viability.